HDFC Life Insur. (HDFCLIFE)

FairStock Score: 40/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 50.21% aligns management and minority shareholder interests
• Low debt/equity of 0.17 reflects a conservative capital structure
• Piotroski F-Score of 7/9 indicates solid operational health
• Latest quarter sales of ₹29,428 Cr show scale with 13% sales growth

Concerns

• Extreme valuation: P/E of 81.65, P/B of 7.99, and PEG of 24.63 against modest profit growth of 9.84%
• Negative free cash flow of ₹-1,246 Cr and Altman Z-Score of 0.62 raise earnings-quality questions
• DCF intrinsic value of ₹80.88 and Graham Number of ₹121.90 imply massive downside from ₹598.20
• ROE of 11.70% does not justify a price-to-book multiple of nearly 8 times

AI Analysis

As I sit at my desk, I measure a business by the relationship between its price and its intrinsic worth. HDFC Life fails that test today. The company is selling at ₹598.20, or 81.65 times trailing earnings. Yet profits grew only 9.84% last year and revenue has compounded at just 8.18% over five years. That puts the PEG at 24.63. A fair price for growth is not a lottery ticket; this is not fair by any measure. Let me check the balance sheet. Debt/equity is low at 0.17 and promoter holding is solid at 50.21%. Piotroski score of 7/9 suggests operations are not deteriorating. But free cash flow is minus ₹1,246 Cr, and Altman Z is 0.62. Accounting income of ₹418 Cr in the latest quarter is not translating into cash. A life insurer needs to sell claims on future premiums, and I have seen many good businesses eaten by the gap between reported earnings and cash need. Graham taught me to demand a margin of safety. Here it is absent, indeed negative. The Graham Number is ₹121.90, while the shares sell at ₹598.20 — over five times that conservative anchor. The DCF intrinsic value of ₹80.88 is even lower. Even ignoring the exact terminal assumptions, a P/B of 7.99 for an ROE of 11.70% is not an appealing trade. I would rather buy a rupee of book value for close to a rupee than for eight rupees. Yes, HDFC Life has brand, distribution and scale; those make it good. Latest sales grew 13%, and the promoter stake aligns interests. But a good business and a good price are different. At this price, for a slow grower earning 9.84% profit growth, I can only say: I will pass. Patience is the investor's best friend.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer